EVOQ Remedies Profit & Loss Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs

1.47 -0.07 (-4.55%)Updated : 11 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	27.01	14.04	5.70	24.13
Net Income After Taxes	-0.24	0.09	0.45	1.62
Income Availableto Com Incl Extra Ord	-0.24	0.09	0.45	1.62
Costof Revenue Total	25.48	13.08	1.56	19.33
Other Net	1.25	2.41	2.26	6.02
Gross Profit	0.03	-1.32	2.50	1.06
Diluted Weighted Average Shares	2.40	2.49	1.36	1.36
Diluted Net Income	-0.24	0.09	0.45	1.62
Provisionfor Income Taxes	-0.01	0.04	0.16	0.67
Depreciation/ Amortization	0.05	0.05	0.01	0.00
period Type	-	-	-	-
Net Income Before Extra Items	-0.24	0.09	0.45	1.62
Total Revenue	25.51	11.76	4.05	20.39
Operating Income	-1.50	-2.29	-1.65	-3.74
Net Income	-0.24	0.09	0.45	1.62
period Length	12.00	12.00	12.00	12.00
Revenue	25.51	11.76	4.05	20.39
Income Availableto Com Excl Extra Ord	-0.24	0.09	0.45	1.62
Selling/ General/ Admin Expenses Total	0.07	0.07	0.08	0.20
Other Operating Expenses Total	1.41	0.84	4.06	4.59
Net Income Before Taxes	-0.25	0.13	0.61	2.28
Diluted Normalized EPS	-0.10	0.04	0.33	1.19
Diluted EPS Excluding Extra Ord Items	-0.10	0.04	0.33	1.19